2 completed, 2 not yet recruiting, 1 withdrawn. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Not yet recruiting 2, Withdrawn 1 |
Follow bimekizumab: new trials by email Literature Review of bimekizumab trials Research Report on bimekizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bimzelx (Bimekizumab) For The Treatment Of Adult Onset Pityriasis Rubra Pilaris (PRP) Bimekizumab - Pityriasis Rubra Pilaris | Phase 4 | Not yet recruiting | Mayo Clinic | 12 | 2026-10-01 | 2026-09-08 |
| Utilization of a Microdevice for Psoriasis and Atopic Dermatitis In situ cutaneous microdevice, Triamcinolone, 5-Fluorouracil - Psoriasis, Atopic Dermatitis | Phase 4 | Not yet recruiting | University of California, San Francisco | 10 | 2026-08-01 | 2026-06-03 |
| Bimekizumab in Plaque Psoriasis Bimekizumab - Plaque Psoriasis | Phase 4 | Completed | Icahn School of Medicine at Mount Sinai | 60 | 2024-06-03 | 2026-04-20 |
| Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis Bimekizumab - Psoriasis Vulgaris, Active Psoriatic Arthritis | Phase 4 | Withdrawn | Innovaderm Research Inc. | 2023-01-01 | 2023-03-15 | |
| Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis Secukinumab, Ixekizumab, Brodalumab - Psoriasis, Psoriasis Vulgaris | Phase 4 | Completed | Radboud University Medical Center | 244 | 2020-08-20 | 2026-03-17 |
Psoriasis (2) · Arthritis, Psoriatic (1) · Dermatitis, Atopic (1) · Pityriasis Rubra Pilaris (1) · Skin Diseases (1) · Skin Diseases, Papulosquamous (1)
Icahn School of Medicine at Mount Sinai (1) · Innovaderm Research Inc. (1) · Mayo Clinic (1) · Radboud University Medical Center (1) · University of California, San Francisco (1)
United States (3) · Belgium (1) · Netherlands (1)
Elke de Jong, MD, PhD (1) · Jason C. Sluzevich, MD (1) · Mark Lebwohl, MD (1) · Raymond Cho, MD, PhD (1) · Robert Bissonnette, MD (1)
2019 (1)